CryoLife Announces Sale of PerClot to Baxter

ATLANTA, July 29, 2021 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerClot product line to a subsidiary of Baxter International, Inc. (“Baxter”) (NYSE: BAX ), for up to $60.8 million in cash. Of the $60.8 million, CryoLife will receive […]

Teleflex Reports Second Quarter 2021 Results and Full Year Outlook

WAYNE, Pa., July 29, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended June 27, 2021. Second quarter financial summary Reported revenues of $713.5 million, up 25.8% year-over-year; up 21.0% on a constant currency basis GAAP diluted EPS from continuing operations of […]

LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2021. For the second quarter of 2021, worldwide sales from continuing operations were $264.5 million, an increase of 45.2 percent on a reported basis and 41.0 percent on a […]

Venus Medtech Appoints Professor Martin B. Leon as Global Principal Investigator of Its New-Generation RDN System

HANGZHOU, China, July 28, 2021 /PRNewswire/ — On July 27, 2021, Venus Medtech (Hangzhou) Inc. (“Venus Medtech”) (stock code: 2500.HK), a leading provider of comprehensive interventional heart valve therapy solutions in China, and its controlling subsidiary Renaly Ltd., announced that Professor Martin B. Leon, MD, a pioneer in the field of interventional cardiovascular devices, has been appointed as […]

MicroPort® Cardiac Rhythm Management Business Announces US$150 Million Series C Investment

SHANGHAI, July 27, 2021 /PRNewswire/ — MicroPort Scientific Corporation (“MicroPort®“) announced that MicroPort Cardiac Rhythm Management Limited (“MicroPort® CRM“), which is MicroPort®‘s subsidiary focused on developing and commercializing implantable pacemaker and defibrillator devices and related technologies to manage cardiac rhythm disorders, has entered into definitive agreements in connection with its Series C financing […]

Boston Scientific Announces Results For Second Quarter 2021

MARLBOROUGH, Mass., July 27, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.077 billion during the second quarter of 2021, growing 53.6 percent on a reported basis, 49.6 percent on an operational1 basis and 52.4 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income […]

CorMatrix® Cardiovascular, Inc. Completes Growth Financing Led by Jam Capital Partners

Leading Developer of Regenerative Cardiovascular Products to Complete FDA Clinical Trial and Advance Other Technologies in Treatment of Heart Disease ATLANTA, July 27, 2021 /PRNewswire/ — CorMatrix® Cardiovascular, Inc., ( is a leading developer of regenerative cardiovascular products and is working on a portfolio of groundbreaking regenerative heart valve products for individuals with valve […]

MiRus™ Raises $65 Million For Expansion of Rhenium-based Medical Devices

ATLANTA, July 27, 2021 /PRNewswire/ — MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions using its proprietary Rhenium-based alloys (MoRe®).  The round was led by Mammoth Scientific and multi-generational family offices […]

Q’Apel Medical Announces Move to New Headquarters Facility in Fremont, CA

New 35,000 square foot Facility will support the company’s growth and OUS expansion FREMONT, Calif., July 27, 2021 /PRNewswire/ — Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today that it will relocate its existing headquarters into a new building at […]